Halozyme Therapeutics Inc (HALO)
46.93
-0.39
(-0.82%)
USD |
NASDAQ |
Dec 20, 16:00
46.95
+0.02
(+0.04%)
After-Hours: 20:00
Halozyme Therapeutics Total Assets (Quarterly): 2.118B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Lexicon Pharmaceuticals Inc | 321.12M |
| Novavax Inc | 1.712B |
| Kura Oncology Inc | 478.84M |
| TransMedics Group Inc | 785.57M |
| Pulmonx Corp | 167.40M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.665B |
| Shareholders Equity (Quarterly) | 452.70M |
| Debt to Equity Ratio | 3.323 |
| Current Ratio | 10.36 |
| Net Debt Paydown Yield | -0.02% |